Evidence map›Paper›PMID 33374578›Full record

ReviewNutrients2020

Aging, Gut Microbiota and Metabolic Diseases: Management through Physical Exercise and Nutritional Interventions.

María Juárez-Fernández, David Porras, María Victoria García-Mediavilla, Sara Román-Sagüillo, Javier González-Gallego, Esther Nistal, Sonia Sánchez-Campos

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Antioxidants (Basel, Switzerland) · 2024
    Article
  17. Review
  18. Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious.International journal of molecular sciences · 2024
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

María Juárez-FernándezInstitute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.ORCID 0000-0003-4678-3058
David PorrasInstitute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.
María Victoria García-MediavillaInstitute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.
Sara Román-SagüilloInstitute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.
Javier González-GallegoInstitute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.ORCID 0000-0002-4386-9342
Esther NistalInstitute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.
Sonia Sánchez-CamposInstitute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversidad de León · ES

Funding

Junta de Castilla y León GRS 1888/A/18Ministerio de Ciencia, Innovación y Universidades FPU18/06257Ministerio de Economía, Industria y Competitividad, Gobierno de España BFU2017-87960-R
6 · The paper itself

Abstract

Gut microbiota (GM) is involved in the maintenance of physiological homeostasis, thus the alteration of its composition and functionality has been associated with many pathologies such as metabolic diseases, and could also be linked with the progressive degenerative process in aging. Nowadays, life expectancy is continuously rising, so the number of elder people and the consequent related pathologies demand new strategies to achieve healthy aging. Besides, actual lifestyle patterns make metabolic diseases a global epidemic with increasing trends, responsible for a large mortality and morbidity in adulthood and also compromising the health status of later stages of life. Metabolic diseases and aging share a profile of low-grade inflammation and innate immunity activation, which may have disturbances of GM composition as the leading mechanism. Thus, GM emerges as a therapeutic target with a double impact in the elderly, counteracting both aging itself and the frequent metabolic diseases in this population. This review summarizes the role and compositional changes of the GM in aging and its modulation through nutritional interventions and physical exercise as a strategy to counteract the aging process and the related metabolic diseases.

Indexed as

AgingExercise TherapyGastrointestinal MicrobiomeNutrition TherapyAgedHumansMetabolic DiseasesProbioticsdietary interventionelderlygut microbiotametabolic diseasesphysical exerciseprebioticsprobiotics

Identifiers

PMID33374578
PMCPMC7822442
OpenAlexW3115730781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.